Neuland Laboratories share news and announcements
NSE: NEULANDLABBSE: 524558Pharmaceuticals & BiotechnologySmall Cap
Last close ₹18,865.00down ₹70.00 (0.37%)BSE ₹18,924.25
Share price at the NSE close on 23 Oct 2026. Previous close ₹18,935.00.
52-week range of traded prices to 23 Oct 2026
₹11,500.00Low, 23 Mar 2026₹24,225.00High, 9 Sep 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹24,204 Cr356th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 5 Aug 2026
- 48.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 May 2026
- 12.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.18%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 5 Aug 2026
- 29.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 5 Aug 2026
- 32.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 May 2026
- 0.10
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 53,34748.3% delivered
Neuland Laboratories share news and announcements
836 announcements, routine notices left out, newest first. Page 17 of 17.
Jul 2011
1 Jul · Board meeting
Inter-alia to consider the issue of equity shares on right issue basis to the members of the Company.
Jun 2011
28 Jun · Meeting
Annual General Meeting of the company will be held on August 05, 2011. Further the Register of members and share transfer books of the company will remain closed from August 02, 2011 to August 05, 2011 (both days inclusive) for the purpose of the Annual General Meeting.
May 2011
23 May · Management
Export Import Bank of India (EXIM Bank) has withdrawn the nomination of Ms. Daya Chandrahas and has appointed Mr. Nadeem Panjetan as their Nominee Director on the Board of the Company with effect from April 29, 2011.20 May · Board meeting
Board of Directors of the Company at its meeting held on May 20, 2011 have not recommended any dividend for the financial year ended March 31, 2011.11 May · Board meeting
To inter-alia consider the audited financial results of the company for the year ended March 31, 2011 and consider recommendation of dividend, if any.
Apr 2011
20 Apr · Management
Ms.Mary Monica Braganza has been appointed as Company Secretary and Compliance Officer of the Company w.e.f. April 18, 2011.
Mar 2011
10 Mar · Management
Ms. Deepika Gupta has resigned from the position of Company Secretary and Compliance Officer and relieved from her services w.e.f. March 10, 2011. Mr.N.S. Viswanathan, Vice President-Finance will be acting as Compliance Officer of the Company w.e.f. March 10, 2011 onwards consequent to resignation of Ms.Deepika Gupta.
Feb 2011
Jan 2011
19 Jan · Board meeting
To consider and take on record the Un-audited financial results of the Company for the quarter ended December 31, 2010.
Oct 2010
11 Oct · Board meeting
To consider and take on record the un-audited financial results of the Company for the quarter ended September 30, 2010.
Aug 2010
2 Aug · Management
Shareholders at the Annual General Meeting of the Company held on July 29, 2010, passed the following resolutions with requisite majority : (1) Appointed Mr. H. Dhanrajgir, as Director retiring by rotation; (2) Appointed Mr. P.V. Maiya, as Director retiring by rotation; (3) Appointed M/s. K S Aiyar & Co., as Auditors for the year ending March 31, 2011; (4) Appointed Dr. Cristopher M. Cimarusti as Director, liable to retire by rotation; (5) Re-appointed Dr. D.R.Rao as Chairman and Managing Director of the Company for a period of 5 years w.e.f. April 01, 2009.2 Aug · Meeting
Shareholders at the Annual General Meeting of the Company held on July 29, 2010 passed the following resolutions with requisite majority : (1) Approved monthly remuneration not exceeding Rs. 4,00,000/- to Dr. D.R. Rao as Chairman and Managing Director for a period of 3 years w.e.f. April 01, 2009; (2) Approved monthly remuneration not exceeding Rs. 4,00,000/- to Mr. D. Sucheth Rao, as Whole-time Director and CEO for a period of 3 years w.e.f. April 01, 2009; (3) Approved monthly remuneration not exceeding Rs. 3,50,000/- to Mr. D. Saharsh Rao, as Whole-time Director and President-Contract Research for a period of 3 years w.e.f. June 01, 2009.
Jul 2010
14 Jul · Board meeting
To consider and take on record the Un-audited financial results of the Company for the quarter ended June 30, 2010.
May 2010
29 May · Management
Board of Directors in their meeting held on May 29, 2010 have approved reappointment of Dr. D. R. Rao, as the Chairman and Managing Director of the Company for the period of (5) five years with effect from April 1, 2009 subject to the approval of shareholders in ensuing Annual General Meeting.29 May · Corporate action
Board of Directors in its meeting held on May 29, 2010, have fixed the book closure from July 26, 2010 to July 29, 2010 (both days inclusive) for the purpose of ensuing Annual General Meeting pursuant to Section 154 of the Companies Act 1956 and the Listing Agreement.12 May · Board meeting
Company had informed the exchange that a meeting of the Board of Directors will be held on May 28, 2010 to consider and take on record the Annual Audited Results of the company for the year ended March 31, 2010. The Company has now informed the exchange that the meeting of the Board of Directors of the Company is scheduled to be held on May 29, 2010 to consider and take on record the Annual Audited Results of the company for the year ended March 31, 2010.Not held on this date
7 May · Board meeting
To consider and take on record the annual audited financial results of the company for the year ended March 31, 2010.
Jan 2010
12 Jan · Board meeting
Meeting on 28 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
6 Oct · Board meeting
Meeting on 20 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
Jul 2009
20 Jul · Meeting
Outcome of Annual General of the Company held on July 18, 2009 passed the following resolutions with requisite majority: (1) Appointed Mr.S. B. Budhiraja, as Director retiring by rotation. (2) Appointed Mr. G.V.K. Rama Rao, as Director retiring by rotation. (3) Declared dividend @ Rs.3.50/- per equity share for the financial year 2008-09.(4) Appointed M/s.K.S. Aiyar & Co., as Auditors for the year ending March 31, 2010 (4) Appointed Mr. D. Saharsh Rao as Whole Time Director of the Company designated as President-Contract Research for the period of three years with effects from June 1, 2009.3 Jul · Meeting
Notice of the Annual General Meeting of the Members of the company to be held on July 18, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2009
29 Jun · Meeting
Annual General Meeting of the Shareholders of the Company will be held on July 18, 2009.24 Jun · Board meeting
To consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2009.17 Jun · Management
Ms. Deepika Gupta has joined us as Company Secretary on 13th May 2009 and she will also act as compliance officer of the Company from 13th May 2009 onwards in place of Mr. A. Raghvendracharyulu
May 2009
26 May · Corporate action
Neuland Laboratories Ltd had informed the Exchange regarding the book closure from July 15, 2009 to July 18, 2009 (both days inclusive) for the purpose of ensuing Annual General Meeting. The company has now informed the Exchange that this book closure period is for declaration of dividend purpose as well.22 May · Dividend
Board of Directors in their meeting held today i.e. May 21, 2009:(1)Have proposed a dividend of Rs 3.50 per share on the equity share capital of the company subject to approval of the shareholders in the ensuing Annual General Meeting. (2) Have fixed the book closure from July 15, 2009 to July 18, 2009 (both days inclusive) for the purpose of ensuing Annual General Meeting.(3) Have approved promotion of Mr. D Sucheth Rao as Chief Executive Officer of the company. (4) Have appointed Co-opting of Mr D.Saharsh Rao as additional Director and appointment as Whole Time Director in ensuing Annual General Meeting.
Apr 2009
24 Apr · Demise of Director
Dr.Bandaru S. Reddy, Non-Executive Director on the Board passed away on April 20, 200923 Apr · Change in Compliance officer
That Mr.A. Raghavendracharyulu, Vice President - Finance is acting as Compliance Officer from April 3, 2009 onwards consequent to resignation of Ms.K.Sandhya Lakshmi from the position of Company Secretary.9 Apr · Management
Ms. K. Sandhya Lakshmi has resigned from the position of Company Secretary and relieved from her services w.e.f. 02.04.20099 Apr · Board meeting
To consider and take on record the audited financial results of the company for the year ended March 31, 2009. Further the Company has informed that the company is not declaring un-audited results for the quarter ended March 31, 2009.
Jan 2009
9 Jan · Board meeting
Meeting on 22 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Nov 2008
26 Nov · Grant of Options
Shareholders of the Company at the Annual General Meeting held on July 20, 2007 approved issue of stock options to employees & employees of subsidiary companies of the company up to a maximum of 3% of the paid up capital of the Company. The Compensation Committee has passed a resolution approving the Employee Stock Option Scheme 2008 and grant of 34500 options to employees at an exercise price of Rs. 104/- per share on November 20, 2008.